From Pulse 2.0 · Amit Chowdhry · · 1m 40s
TL;DR: Marrow Therapeutics Launches With $173 Million
Marrow Therapeutics secures $173 million for bone marrow-targeted medicines to treat blood disorders.
Marrow Therapeutics received $173 million in funding to develop genetic medicines for severe blood and bone marrow disorders. Marrow Therapeutics secures $173 million for bone marrow-targeted medicines to treat blood disorders. Marrow Therapeutics has launched with $173 million in combined Series A and Series B funding to develop genetic medicines for severe blood and bone marrow disorders.
- Funding Announcement
- Funding Breakdown
- Investors
- Company Background
Read the story version — the same reporting as a swipeable deck of 9 cards.

